Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Bowden currently holds 44,167 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Bowden has been a net seller of AGIO stock. They have purchased $0 and sold $13.2M worth of shares.
Christopher Bowden's most recent insider trade was on Jun 22, 2022, when they sold 40,000 shares at $0.00 per share.
Christopher Bowden serves as Executive at AGIOS PHARMACEUTICALS, INC. (AGIO). They have executed 84 insider transactions totaling $13.2M over their tenure at the company.
Christopher Bowden holds the position of Executive at AGIOS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Christopher Bowden has shown a selling trading pattern, with $0 in total purchases and $13.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Bowden was on Jun 18, 2021, when they sold $2.9M worth of AGIO shares. This transaction involved 48,493 shares at $60.11 per share.
Christopher Bowden currently owns 44,167 shares of AGIOS PHARMACEUTICALS, INC. (AGIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Bowden's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Bowden has 84 Form 4 filings on record as an insider at AGIOS PHARMACEUTICALS, INC..
Set alerts for Christopher Bowden and 40,000+ other insiders.